Chondrodysplasia Blomstrand
Chondrodysplasia Blomstrand is a rare, autosomal recessive genetic disorder characterized by advanced skeletal maturation, short limb dwarfism, facial anomalies, and early lethality. First described by Blomstrand et al., this condition is a severe form of skeletal dysplasia, which affects the development of bones and cartilage in the body.
Etiology[edit | edit source]
Chondrodysplasia Blomstrand is caused by mutations in the P450 Oxidoreductase (POR) gene, which plays a crucial role in the synthesis of cholesterol and steroid hormones. These mutations lead to a disruption in the normal process of bone growth and development, resulting in the characteristic features of the disorder.
Pathophysiology[edit | edit source]
The pathophysiology of Chondrodysplasia Blomstrand involves abnormal bone ossification and maturation. The condition is characterized by a process called osteochondrodysplasia, where there is defective growth and development of both bone and cartilage. The mutations in the POR gene affect the regulation of bone growth factors, leading to premature ossification of the skeleton.
Clinical Features[edit | edit source]
Individuals with Chondrodysplasia Blomstrand typically present with:
- Short stature due to short limbs
- Facial anomalies including a prominent forehead, depressed nasal bridge, and micrognathia (small jaw)
- Advanced bone age
- Respiratory difficulties due to a narrow chest cavity
- Polyhydramnios during pregnancy
Diagnosis[edit | edit source]
Diagnosis of Chondrodysplasia Blomstrand is primarily based on clinical examination and radiographic findings. Prenatal ultrasound may reveal signs of the disorder, such as polyhydramnios and shortened limbs. Genetic testing can confirm the diagnosis by identifying mutations in the POR gene.
Treatment[edit | edit source]
There is no cure for Chondrodysplasia Blomstrand, and treatment is supportive and symptomatic. Management may include:
- Orthopedic interventions to address skeletal abnormalities
- Respiratory support for those with chest wall deformities
- Regular monitoring and management of potential complications
Prognosis[edit | edit source]
The prognosis for individuals with Chondrodysplasia Blomstrand is poor, with most affected infants dying in utero or shortly after birth due to respiratory failure. However, the severity of the condition can vary, and a small number of individuals have survived into childhood with intensive medical support.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD